A Revlimid pill costs about 25 cents to make, and about a thousand dollars to buy—but it’s keeping him alive, so what choice does he have?

Guest: David Armstrong, investigates healthcare at ProPublica, author of “The Price of Remission.”

Want more What Next? Subscribe to Slate Plus to access ad-free listening to the whole What Next family and across all your favorite Slate podcasts. Subscribe today on Apple Podcasts by clicking “Try Free” at the top of our show page. Sign up now at slate.com/whatnextplus to get access wherever you listen.

Podcast production by Ethan Oberman, Elena Schwartz, Paige Osburn, Anna Phillips, Madeline Ducharme, Isabel Angell, and Rob Gunther.

Learn more about your ad choices. Visit megaphone.fm/adchoices